Impact of Non-ABL1 Mutations on Outcomes in Chronic Myeloid LeukemiaByAkriti Jain, MDJanuary 6th 2025Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
Exciting Advances in AML Treatment: Jain on Key Highlights for ASH 2024ByAkriti Jain, MDDecember 6th 2024Akriti Jain, MD, discusses what she is most looking forward to seeing presented at the upcoming 2024 American Society of Hematology Annual Meeting and Exposition.